» Articles » PMID: 23744360

Redox Cycling of Endogenous Copper by Thymoquinone Leads to ROS-mediated DNA Breakage and Consequent Cell Death: Putative Anticancer Mechanism of Antioxidants

Overview
Journal Cell Death Dis
Date 2013 Jun 8
PMID 23744360
Citations 48
Authors
Affiliations
Soon will be listed here.
Abstract

Plant-derived dietary antioxidants have attracted considerable interest in recent past for their chemopreventive and cancer therapeutic abilities in animal models. Thymoquinone (TQ) is the major bioactive constituent of volatile oil of Nigella sativa and has been shown to exert various pharmacological properties, such as anti-inflammatory, cardiovascular, analgesic, anti-neoplastic, anticancer and chemopreventive. Although several mechanisms have been suggested for the chemopreventive and anticancer activity of TQ, a clear mechanism of action of TQ has not been elucidated. TQ is a known antioxidant at lower concentrations and most of the studies elucidating the mechanism have centered on the antioxidant property. However, recent publications have shown that TQ may act as a prooxidant at higher concentrations. It is well known that plant-derived antioxidants can switch to prooxidants even at low concentrations in the presence of transition metal ions such as copper. It is well established that tissue, cellular and serum copper levels are considerably elevated in various malignancies. Copper is an important metal ion present in the chromatin and is closely associated with DNA bases, particularly guanine. Using human peripheral lymphocytes and comet assay, we first show that TQ is able to cause oxidative cellular DNA breakage. Such a DNA breakage can be inhibited by copper-chelating agents, neocuproine and bathocuproine, and scavengers of reactive oxygen species. Further, it is seen that TQ targets cellular copper in prostate cancer cell lines leading to a prooxidant cell death. We believe that such a prooxidant cytotoxic mechanism better explains the anticancer activity of plant-derived antioxidants.

Citing Articles

Apoptotic effect of thymoquinone on OVCAR3 cells via the P53 and CASP3 activation.

Karaosmanoglu O, Kamalak Z, Ozdemir I, Ozturk S, Tuncer M Acta Cir Bras. 2024; 39:e399224.

PMID: 39536185 PMC: 11548134. DOI: 10.1590/acb399224.


Understanding the Anticancer Properties of Honey.

Martinotti S, Bonsignore G, Ranzato E Int J Mol Sci. 2024; 25(21).

PMID: 39519281 PMC: 11547017. DOI: 10.3390/ijms252111724.


ATPase Copper Transporting Beta (ATP7B) Is a Novel Target for Improving the Therapeutic Efficacy of Docetaxel by Disulfiram/Copper in Human Prostate Cancer.

Song L, Nguyen V, Xie J, Jia S, Chang C, Uchio E Mol Cancer Ther. 2024; 23(6):854-863.

PMID: 38417139 PMC: 11150099. DOI: 10.1158/1535-7163.MCT-23-0876.


Mechanism of the antidiabetic action of and Thymoquinone: a review.

Shaukat A, Zaidi A, Anwar H, Kizilbash N Front Nutr. 2023; 10:1126272.

PMID: 37818339 PMC: 10561288. DOI: 10.3389/fnut.2023.1126272.


Disulfiram Enhances the Antineoplastic Activity and Sensitivity of Murine Hepatocellular Carcinoma to 5-FU via Redox Management.

Hassan I, Ebaid H, Alhazza I, Al-Tamimi J, Rady A Pharmaceuticals (Basel). 2023; 16(2).

PMID: 37259318 PMC: 9967644. DOI: 10.3390/ph16020169.


References
1.
Bolton J, Trush M, Penning T, Dryhurst G, Monks T . Role of quinones in toxicology. Chem Res Toxicol. 2000; 13(3):135-60. DOI: 10.1021/tx9902082. View

2.
Gali H, Perchellet E, Klish D, Johnson J, Perchellet J . Hydrolyzable tannins: potent inhibitors of hydroperoxide production and tumor promotion in mouse skin treated with 12-O-tetradecanoylphorbol-13-acetate in vivo. Int J Cancer. 1992; 51(3):425-32. DOI: 10.1002/ijc.2910510315. View

3.
Ahmed M, Ramesh V, Nagaraja V, Parish J, Hadi S . Mode of binding of quercetin to DNA. Mutagenesis. 1994; 9(3):193-7. DOI: 10.1093/mutage/9.3.193. View

4.
Quinlan G, Gutteridge J . Oxygen radical damage to DNA by rifamycin SV and copper ions. Biochem Pharmacol. 1987; 36(21):3629-33. DOI: 10.1016/0006-2952(87)90012-8. View

5.
Nagi M, Mansour M . Protective effect of thymoquinone against doxorubicin-induced cardiotoxicity in rats: a possible mechanism of protection. Pharmacol Res. 2000; 41(3):283-9. DOI: 10.1006/phrs.1999.0585. View